Shashikant Lele
- Reproductive Medicine top 0.2%
- Ovarian cancer diagnosis and treatment 27
- Obstetrics and Gynecology top 1%
- Endometrial and Cervical Cancer Treatments 5
- Surgery top 2%
- Intraperitoneal and Appendiceal Malignancies 10
- Testicular diseases and treatments 3
- Emergency Medicine top 5%
- Oncology top 5%
-
- Renal cell carcinoma treatment 3
-
- Renal and related cancers 3
-
- BRCA gene mutations in cancer 2
-
- Cancer, Lipids, and Metabolism 2
Shashikant Lele
29 papers receiving 2.4k citations
Hit Papers
Peers
Comparison fields: 5 of 94
- Reproductive Medicine 1.6k
- Obstetrics and Gynecology 420
- Surgery 1.3k
- Emergency Medicine 203
- Oncology 560
Countries citing papers authored by Shashikant Lele
This map shows the geographic impact of Shashikant Lele's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shashikant Lele with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shashikant Lele more than expected).
Fields of papers citing papers by Shashikant Lele
This network shows the impact of papers produced by Shashikant Lele. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shashikant Lele. The network helps show where Shashikant Lele may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shashikant Lele, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 2 | |
| 2 | 2019 | 1 | |
| 3 | 2014 | 19 | |
| 4 | 2013 | 2 | |
| 5 | 2012 | 40 | |
| 6 | 2012 | 15 | |
| 7 | 2011 | 16 | |
| 8 | 2011 | 5 | |
| 9 | 2010 | 2 | |
| 10 | 2008 | 33 | |
| 11 | 2007 | 21 | |
| 12 | 2006 | 23 | |
| 13 | Primary fallopian tube carcinoma: a retrospective clinicopathologic study. | 2006 | 10 |
| 14 | 2005 | 43 | |
| 15 | 2004 | 25 | |
| 16 | 2004 | 17 | |
| 17 | 2004 | 30 | |
| 18 | 2004 | 2 | |
| 19 | 2003 | 34 | |
| 20 | Recombinant CD40 ligand therapy has significant antitumor effects on CD40-positive ovarian tumor xenografts grown in SCID mice and demonstrates an augmented effect with cisplatin. | 2001 | 76 |
About Shashikant Lele
Shashikant Lele is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Surgery, having authored 29 papers that have together received 2.5k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (27 papers), Intraperitoneal and Appendiceal Malignancies (10 papers), Endometrial and Cervical Cancer Treatments (5 papers), Renal cell carcinoma treatment (3 papers), Testicular diseases and treatments (3 papers), Renal and related cancers (3 papers), BRCA gene mutations in cancer (2 papers) and Cancer, Lipids, and Metabolism (2 papers). The work is most often cited by research in Reproductive Medicine (1.6k citations), Obstetrics and Gynecology (420 citations) and Surgery (1.3k citations). Shashikant Lele has collaborated with scholars based in United States and Germany. Frequent co-authors include Deborah K. Armstrong, Larry J. Copeland, Brian N. Bundy, Joan L. Walker, Robert A. Burger, Helen Huang, Rebecca N. Baergen, Lari Wenzel, Kunle Odunsi and Paulette Mhawech‐Fauceglia. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.